NeuroOne Hits Wall Street

Adapted from the NeuroOne Press Release written 11/22/22:

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), rang the Nasdaq closing bell yesterday to commemorate the Evo® thin film electrode platform.

WITNe’s Co-Director, Justin Williams, is part of the NeuroOne Medical Technologies Corporation. NeuroOne is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.

Learn more about NeuroOne and it’s incredible achievements at